A non-randomized, open-label study of the safety and effectiveness

Treatment Efficacy of Targeted Therapies for Metastatic Renal Cell

Equillium - Final Safety and Efficacy Results from EQUATE, an Open

Change in LYMQOL during study period. LYMQOL Lymphedema Quality of Life

Stanley ROCKSON, Allan and Tina Neill Professor of Lymphatic Research and Medicine/Chief of Consultative Cardiology, Stanford University, CA, SU, Division of Cardiovascular Medicine

Pinar KARACA-MANDIC, Assistant Professor, Ph.D, Economics, U.C. Berkeley, University of Minnesota Twin Cities, MN, UMN, Division of Health Policy and Management

PDF) A non-randomized, open-label study of the safety and effectiveness of a novel non-pneumatic compression device (NPCD) for lower limb lymphedema

Considerations for open-label clinical trials: design, conduct

Quantitative Research: What It Is, Practices & Methods

Lymphedema techniques to manage edema after SCI: a retrospective analysis

Stanley ROCKSON, Allan and Tina Neill Professor of Lymphatic Research and Medicine/Chief of Consultative Cardiology, Stanford University, CA, SU, Division of Cardiovascular Medicine

Randomized and nonrandomized studies: Complementary or competing

Sample size calculator

Disturbed Thought Processes (Cognitive Impairment) Nursing